Belite Bio Inc Sustainability Reports
Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the research and development of novel therapeutics for eye diseases involving retinal degeneration.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 984500BD54036BOEAE79
FIGI: BBG016LJYTW4
1 reports from 2022 to 2022
